Marker Therapeutics, Inc. (MRKR) Financials

MRKR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 17.4 million 3.6 million
Dec. 31, 2025 19.1 trillion 2.3 trillion
Sept. 30, 2025 21.7 million 3.3 million
June 30, 2025 14.8 million 4.3 million

MRKR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.4 million 178422
Dec. 31, 2025 -1.9 million 111131
Sept. 30, 2025 -2.7 million 33279
June 30, 2025 -1.9 million 13986

MRKR Net Income

No data available :(

MRKR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 14.9 million - -
Dec. 31, 2025 16.1 trillion - -
Sept. 30, 2025 17.6 million - -
June 30, 2025 10.5 million - -

MRKR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 19.3 million
Dec. 31, 2025 15.3 million
Sept. 30, 2025 16.8 million
June 30, 2025 14.0 million

MRKR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2 2.8 million 1.2 million -
Dec. 31, 2025 - 2.1 million 846606 -
Sept. 30, 2025 4 2.3 million 1.0 million -
June 30, 2025 - 4.2 million 945163 -

MRKR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 1.1 million -
Sept. 30, 2025 1.2 million -
June 30, 2025 861184 4.2 million

MRKR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRKR

Price: $1.33

52 week price:
0.81
4.07

Earnings Per Share: -0.55 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 156064

Market Capitalization: 15.3 million

Links: